Atlas Trials

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Clinical trial NCT02109562 · COMPLETED

Trial details

NCT number
NCT02109562
Sponsor
Indivior Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-04-01
Primary completion
2014-11-01
Enrollment
354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.